These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 34073220)
1. Potential Modulatory Microbiome Therapies for Prevention or Treatment of Inflammatory Bowel Diseases. Bunt DV; Minnaard AJ; El Aidy S Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073220 [TBL] [Abstract][Full Text] [Related]
2. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease. Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876 [TBL] [Abstract][Full Text] [Related]
3. An Insight Into the Intestinal Web of Mucosal Immunity, Microbiota, and Diet in Inflammation. Yap YA; Mariño E Front Immunol; 2018; 9():2617. PubMed ID: 30532751 [TBL] [Abstract][Full Text] [Related]
4. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368 [TBL] [Abstract][Full Text] [Related]
5. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease. Gonçalves P; Araújo JR; Di Santo JP Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379 [TBL] [Abstract][Full Text] [Related]
6. Gut microbiota metabolite regulation of host defenses at mucosal surfaces: implication in precision medicine. Bilotta AJ; Cong Y Precis Clin Med; 2019 Jun; 2(2):110-119. PubMed ID: 31281735 [TBL] [Abstract][Full Text] [Related]
7. Role of metabolites derived from gut microbiota in inflammatory bowel disease. Zheng L; Wen XL; Duan SL World J Clin Cases; 2022 Mar; 10(9):2660-2677. PubMed ID: 35434116 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Lavelle A; Sokol H Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145 [TBL] [Abstract][Full Text] [Related]
9. Synergic interactions between polyphenols and gut microbiota in mitigating inflammatory bowel diseases. Li H; Christman LM; Li R; Gu L Food Funct; 2020 Jun; 11(6):4878-4891. PubMed ID: 32490857 [TBL] [Abstract][Full Text] [Related]
10. Inflammatory Bowel Disease: A Potential Result from the Collusion between Gut Microbiota and Mucosal Immune System. Yue B; Luo X; Yu Z; Mani S; Wang Z; Dou W Microorganisms; 2019 Oct; 7(10):. PubMed ID: 31614539 [TBL] [Abstract][Full Text] [Related]
11. Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease. Nie Y; Lin Q; Luo F Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28654020 [TBL] [Abstract][Full Text] [Related]
13. Gut Microbiota and Immune System Interactions. Yoo JY; Groer M; Dutra SVO; Sarkar A; McSkimming DI Microorganisms; 2020 Oct; 8(10):. PubMed ID: 33076307 [TBL] [Abstract][Full Text] [Related]
14. The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies. West CE; Renz H; Jenmalm MC; Kozyrskyj AL; Allen KJ; Vuillermin P; Prescott SL; J Allergy Clin Immunol; 2015 Jan; 135(1):3-13; quiz 14. PubMed ID: 25567038 [TBL] [Abstract][Full Text] [Related]
15. Butyrate: A Link between Early Life Nutrition and Gut Microbiome in the Development of Food Allergy. Di Costanzo M; De Paulis N; Biasucci G Life (Basel); 2021 Apr; 11(5):. PubMed ID: 33922797 [TBL] [Abstract][Full Text] [Related]
16. Can the gastrointestinal microbiota be modulated by dietary fibre to treat obesity? Davis HC Ir J Med Sci; 2018 May; 187(2):393-402. PubMed ID: 29038988 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications. Shamoon M; Martin NM; O'Brien CL Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403 [TBL] [Abstract][Full Text] [Related]
18. Gut-brain Axis: Role of Lipids in the Regulation of Inflammation, Pain and CNS Diseases. Russo R; Cristiano C; Avagliano C; De Caro C; La Rana G; Raso GM; Canani RB; Meli R; Calignano A Curr Med Chem; 2018; 25(32):3930-3952. PubMed ID: 28215162 [TBL] [Abstract][Full Text] [Related]
19. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease. Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835 [TBL] [Abstract][Full Text] [Related]
20. The Relationship Between Gut Microbiota and Inflammatory Diseases: The Role of Macrophages. Wang J; Chen WD; Wang YD Front Microbiol; 2020; 11():1065. PubMed ID: 32582063 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]